NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 36 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,000 | -69.6% | 42,500 | -20.6% | 0.00% | -100.0% |
| Q2 2022 | $56,000 | -44.6% | 53,500 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $101,000 | -32.7% | 53,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $150,000 | -43.8% | 53,500 | -27.7% | 0.00% | -50.0% |
| Q3 2021 | $267,000 | +93.5% | 74,000 | +156.9% | 0.00% | +100.0% |
| Q2 2021 | $138,000 | -59.9% | 28,800 | -38.1% | 0.00% | -60.0% |
| Q1 2021 | $344,000 | -5.5% | 46,550 | -10.6% | 0.01% | -16.7% |
| Q4 2020 | $364,000 | +136.4% | 52,050 | +155.8% | 0.01% | +100.0% |
| Q3 2020 | $154,000 | – | 20,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 906,445 | $3,272,000 | 1.04% |
| Greenlight Capital | 2,727,027 | $9,844,000 | 0.66% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 407,500 | $1,471,000 | 0.54% |
| CM Management, LLC | 75,000 | $271,000 | 0.20% |
| Stonepine Capital Management, LLC | 109,742 | $396,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 351,178 | $1,268,000 | 0.13% |
| PERKINS CAPITAL MANAGEMENT INC | 21,000 | $76,000 | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $1,123,000 | 0.03% |
| Polar Asset Management Partners Inc. | 634,618 | $2,291,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,250,000 | $4,513,000 | 0.02% |